Mepolizumab
Modify Date: 2024-01-13 12:50:03
Mepolizumab structure
|
Common Name | Mepolizumab | ||
|---|---|---|---|---|
| CAS Number | 196078-29-2 | Molecular Weight | 762.96600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C42H66O12 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MepolizumabMepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma[1][2]. |
| Name | (2S,3S,4S,5R,6R)-6-[[(4aR,6aR,6bS,8aS,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-yl]oxy]-3,5-dihydroxy-4-[(1R,2R,3S,4R)-2,3,4-trihydroxycyclohexyl]oxyoxane-2-carboxylic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C42H66O12 |
|---|---|
| Molecular Weight | 762.96600 |
| Exact Mass | 762.45500 |
| PSA | 203.44000 |
| LogP | 4.56360 |
| Mepolizumab |
| Bosatria |